Hepatocellular carcinoma patients with undetectable baseline hepatitis B viral DNA may benefit from immunotherapy
{{output}}
Background: The relationship between hepatitis B virus (HBV) load and the survival or safety of immunotherapy in patients with advanced hepatocellular carcinoma (HCC) remains ambiguous. ... ...
